| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1110155356 |
| P356 | DOI | 10.1038/S41541-018-0093-1 |
| P932 | PMC publication ID | 6265323 |
| P698 | PubMed publication ID | 30510776 |
| P50 | author | Xavier Saelens | Q8043303 |
| P2093 | author name string | T U Vogel | |
| T Ysenbaert | |||
| H Kleanthous | |||
| A Smet | |||
| E O Oloo | |||
| E R Job | |||
| I Christopoulou | |||
| R P Oomen | |||
| T Strugnell | |||
| P2860 | cites work | A generic system for the expression and purification of soluble and stable influenza neuraminidase | Q21091069 |
| Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses | Q24615003 | ||
| Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells | Q27469883 | ||
| MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability | Q27860817 | ||
| Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses | Q28387782 | ||
| ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules | Q28914720 | ||
| Functional balance between neuraminidase and haemagglutinin in influenza viruses. | Q30248966 | ||
| Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines | Q30356933 | ||
| Neutrophils Ameliorate Lung Injury and the Development of Severe Disease during Influenza Infection | Q57077389 | ||
| Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences | Q84557620 | ||
| Immunogenicity of novel consensus-based DNA vaccines against avian influenza. | Q30359911 | ||
| Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades. | Q30371649 | ||
| Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. | Q30384878 | ||
| Universal influenza vaccines: Shifting to better vaccines. | Q30386388 | ||
| Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies | Q30386823 | ||
| Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets | Q30392305 | ||
| Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains | Q30396097 | ||
| Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir | Q30399269 | ||
| Assessment of influenza A neuraminidase (subtype N1) potency by ELISA. | Q30399415 | ||
| Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques | Q30427950 | ||
| Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies | Q30430925 | ||
| The influenza virus resource at the National Center for Biotechnology Information | Q33303008 | ||
| Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens | Q33346277 | ||
| Human cytotoxic T-lymphocyte repertoire to influenza A viruses | Q33785232 | ||
| In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen | Q33820732 | ||
| A universal influenza A vaccine based on the extracellular domain of the M2 protein | Q33875466 | ||
| Glycosylation site alteration in the evolution of influenza A (H1N1) viruses | Q33987971 | ||
| Integrating influenza antigenic dynamics with molecular evolution | Q34039764 | ||
| Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season | Q34480810 | ||
| Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers | Q35139986 | ||
| A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody | Q35225083 | ||
| Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. | Q35677624 | ||
| Influenza neuraminidase | Q35791130 | ||
| Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection | Q36515143 | ||
| Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model | Q37123064 | ||
| Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus | Q37369509 | ||
| Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 | ||
| A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice | Q39048437 | ||
| Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. | Q40075978 | ||
| Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration | Q40207930 | ||
| Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients | Q40558910 | ||
| A 2 (N2) neuraminidase of the X-7 influenza virus recombinant: determination of molecular size and subunit composition of the active unit | Q40636448 | ||
| An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera | Q42186897 | ||
| Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics. | Q43175970 | ||
| Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine | Q45382232 | ||
| Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model | Q45407370 | ||
| Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza | Q47426452 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 55 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | NPJ Vaccines | Q30275609 |
| P1476 | title | Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs | |
| P478 | volume | 3 |
| Q89965369 | Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics |
| Q92376654 | Computational Approaches and Challenges to Developing Universal Influenza Vaccines |
| Q92376471 | Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase |
| Q91925447 | Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus |
| Q89723360 | Next-generation influenza vaccines: opportunities and challenges |
Search more.